The 4th International Conference on Biological Engineering and Medical Science (ICBioMed 2024) is in the fields of Biological Engineering, Biomedical Engineering, Bioinformatics, Basic Science of Medicine, Clinical and Public Health. This conference serves as an academic platform for international scholars, researchers, and everyone interested in relevant fields to share their inspirations and achievements.
ICBioMed is dedicated to fostering scholarly interaction and dialogue in the areas of bioengineering and medicine. It invites experts and enthusiasts in these domains to share their research and insights through papers or presentations. This initiative is designed to spark new ideas and foster collaborative opportunities within the ICBioMed community.
The topics of interest include but are not limited to:
October 25, 2024
Type | Early Bird Submission | Regular Submission | Late Submission |
---|---|---|---|
Paper Submission | June 27, 2024 | July 29, 2024 | October 25, 2024 |
Review Process | 2 weeks | 2 weeks | 2 weeks |
Registration & Payment | July 08, 2024 | August 06, 2024 | October 25, 2024 |
The submission will first be reviewed for its topic and length, then go through an originality check. The peer-review process will begin soon after the paper is found to be qualified. The paper will be sent to have a double-blind peer review by 2 reviewers. They will judge the paper based on the theme, coverage, innovation, integrity, depth, and language. If the paper is accepted, notification of acceptance and review comments will be sent to the author via email. The actual review time may be different under certain situations.
We call for excellent papers and review them according to the requirements of each journal. Qualified submissions will be directly recommended for publication in the following journals or corresponding Special Issues. The journals listed below have been indexed by Science Citation Index (SCI)/Science Citation Index Expanded (SCI-E) and/or Social Science Citation Index (SSCI):
Please refer to the 'Information > Publication' page for specific recommendation rules and guidelines.
The paper accepted by ICBioMed 2024 will be published in Conference proceedings. They will be submitted to Conference Proceedings Citation Index (CPCI), Crossref, CNKI, Portico, Engineering Village (Inspec), Google Scholar, and other databases for indexing. The situation may be affected by factors among databases like processing time, workflow, policy, etc.
Please follow this link to find more info & requirements about submitting your paper
Submission InfoThe 3rd International Conference on Biological Engineering and Medical Science (ICBioMed 2023) was held online from September 2 to 9. The accepted papers will be published in Proceedings of SPIE (Print ISSN 0277-786X) or Theoretical and Natural Science (Print ISSN 2753-8818). Dr. Maher G. Nawaf from University of Birmingham and 4 other professors from all around the world have chaired workshops on related topics. Dr. Andre Levchenko from Yale University, Dr. Alan Wang from Auckland University and other 8 researchers have given keynote speeches. Also our authors were invited to deliver an oral presentation at the virtual conference. Questions from the audience were collected and answered by the presenters. This conference provided the participant good opportunities to exchange ideas and build networks, and it will lead to the further collaborations between both universities and other societies.
You can follow THIS LINK for more details.
We welcome prospective scholars to submit their novel research or technological contributions to ICBioMed 2024 and share their valuable experiences with other scientists and students from all over the world.
Principal investigators, scientists, professors, engineers, managers, R&D professionals, postdoctoral researchers, and graduate students involved in Biological Engineering and Medical Science will attend and benefit from ICBioMed 2024.
We sincerely welcome professors, associate professors, lecturers and other experts in the areas of Biological Engineering and Medical Science research to join the conference as reviewers. Please feel free to email us at info@icbiomed.org to request further information if you are interested. Your request will be processed in 5 workdays.
If you are interested in giving a presentation at the conference without publishing your paper in the proceeding, you can attend ICBioMed 2024 as presenter. As a presenter, you need to submit the abstract and title of your presentation before registration. For further information, please feel free to contact us at info@icbiomed.org.
ICBioMed 2024 is an unmissable conference. It is a good opportunity and an effective method to meet many renowned experts and researchers in the fields of Biological Engineering and Medical Science research. You are more than welcome to attend this great event. For further information, please feel free to contact us at info@icbiomed.org.
Alan Wang is a principal investigator and Associate Professor at University of Auckland. He has more than ten years of research experience in bioengineering informatics and integrated medicine, especially in advancing the role of medical informatics in health care. His research interests include bioengineering, data informatics, neurocomputing, and biomedical statistics and simulation. He has developed medical data analytics methods for mobile health and personalized diagnosis and prognosis based on intelligent computing theories. He has experience analyzing huge cohorts of patient data with applications of early diagnosis, disease understanding, and effective treatment of patients with different disorders. He serves as an Editorial Board Member and an Active Reviewer for several international journals.
Dr. Byeongsang Oh is an Associate Professor at the Sydney Medical School, University of Sydney, and a Visiting Professor at the University of Kansas Medical School, USA. He also serves as President of the Medical Tai Chi Qigong Association (iMTQA) in the USA. With extensive research and clinical experience at the Dana-Farber Cancer Institute and Harvard Medical School, Dr. Oh is a leading expert in integrative oncology, specializing in evidence-based complementary and lifestyle medicine. His clinical and research focus on lifestyle medicine with a particular emphasis on the microbiome. Currently, he is actively engaged in collaborative integrative oncology research projects with Harvard Medical School and Yale University.